Business Description
Laboratorio Farmaceutico Erfo SpA
ISIN : IT0005497885
Total Employee Number:
50Compare
Compare
Traded in other countries / regions
ERFO.ItalyRK7.Germany IPO Date
2022-06-29Description
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.78 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 0.67 | |||||
Interest Coverage | 18.79 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.94 | |||||
Beneish M-Score | -2.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 29.3 | |||||
3-Year EBITDA Growth Rate | 9.8 | |||||
3-Year EPS without NRI Growth Rate | -16 | |||||
3-Year FCF Growth Rate | -61.3 | |||||
3-Year Book Growth Rate | 34.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 89.2 | |||||
9-Day RSI | 74.96 | |||||
14-Day RSI | 64.72 | |||||
3-1 Month Momentum % | 0.93 | |||||
6-1 Month Momentum % | -25.85 | |||||
12-1 Month Momentum % | -16.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.91 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 145.89 | |||||
Days Sales Outstanding | 35.42 | |||||
Days Payable | 86.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.8 | |||||
Shareholder Yield % | -10.79 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 69.58 | |||||
Operating Margin % | 11.87 | |||||
Net Margin % | 3.95 | |||||
EBITDA Margin % | 20.87 | |||||
FCF Margin % | -17.04 | |||||
OCF Margin % | 9.51 | |||||
ROE % | 4.88 | |||||
ROA % | 3.36 | |||||
ROIC % | 8.92 | |||||
3-Year ROIIC % | 0.51 | |||||
ROC (Joel Greenblatt) % | 44.69 | |||||
ROCE % | 12.12 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.47 | |||||
PE Ratio without NRI | 23.3 | |||||
PS Ratio | 1.03 | |||||
PB Ratio | 1.25 | |||||
Price-to-Tangible-Book | 4.07 | |||||
Price-to-Operating-Cash-Flow | 10.78 | |||||
EV-to-EBIT | 9.72 | |||||
EV-to-EBITDA | 5.31 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-FCF | -6.38 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Graham-Number | 2.07 | |||||
| Price-to-Net-Current-Asset-Value | 23.6 | |||||
Earnings Yield (Greenblatt) % | 10.29 | |||||
FCF Yield % | -16.45 | |||||
Forward Rate of Return (Yacktman) % | 1.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Laboratorio Farmaceutico Erfo SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 9.658 | ||
| EPS (TTM) (€) | 0.044 | ||
| Beta | 0.5755 | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.14 | ||
| Volatility % | 37.86 | ||
| 14-Day RSI | 64.72 | ||
| 14-Day ATR (€) | 0.030718 | ||
| 20-Day SMA (€) | 1.1285 | ||
| 12-1 Month Momentum % | -16.15 | ||
| 52-Week Range (€) | 1.01 - 1.8 | ||
| Shares Outstanding (Mil) | 8.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Laboratorio Farmaceutico Erfo SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Laboratorio Farmaceutico Erfo SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.064000 Cash Dividend | 2024-07-01 | 1.16 (+0.00%) |
Show
Entries
Laboratorio Farmaceutico Erfo SpA Frequently Asked Questions
What is Laboratorio Farmaceutico Erfo SpA(MIL:ERFO)'s stock price today?
The current price of MIL:ERFO is €1.18. The 52 week high of MIL:ERFO is €1.80 and 52 week low is €1.01.
When is next earnings date of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO)?
The next earnings date of Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) is .
Does Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) pay dividends? If so, how much?
Laboratorio Farmaceutico Erfo SpA(MIL:ERFO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Laboratorio Farmaceutico Erfo SpA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers